BAX 3000 Therapy for Child with Eczema Feature Story on KTVN Channel 2 in Reno

BAX 3000 Neurological Stress Reduction Therapy by BioVeda Technologies (formerly BioAllergenix) for a Child Patient suffering from severe Eczema as reported by KTVN Channel 2 in Reno Nevada.

BAX 3000 by BioVeda Featured on CBS Atlanta

BioVeda and the BAX 3000 was recently the focus of a feature story by CBS Atlanta, “Allergy Relief Without Needles Or Pills?” Stephanie Fisher, a CBS Atlanta Anchor, reports

BAX 3000 – New Allergy Therapy Comes in LASER Form – News Channel 5.Com – Nashville Tennessee

BAX 3000 News Coverage out of Nashville Tennessee shows positive results for patients suffering from allergies, autism, migraines and other chronic conditions.

BioAllergenix Announces Company Rebranding and Name Change to BioVeda Technologies

Effective September 2009, BioAllergenix is pleased to announce that they are adopting BioVeda Technologies as their new corporate name, representing its growing foothold in the alternative health care market. The name change is symbolic of the company’s commitment to holistic care and allows the expansion of company products and service offerings to its customers.

BAX 3000 Featured in News Broadcast About Allergies

Allergy Symptoms, Traditional Allergy Relief Methods and the BAX 3000 Neurological Stress Reduction Therapy are discussed in this news broadcast.

BioAllergenix Names Joshua Kayne as Executive Vice President, Sales and Marketing

BioAllergenix, an emerging industry leader in holistic and alternative health care, announced that Joshua Kayne has joined the company in the newly created position of Executive Vice President where he is directly responsible for the company’s global sales and marketing. In this role, Kayne will lead the strategic planning for BioAllergenix’s vision and growth as it expands its mindshare among both physicians and patients in this market.

Page 1 of 212